Clinical Trial

Quantification of Visually Evoked Cortical Potentials in Individuals With Hearing Loss

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 29, 2025 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This research is being done to determine whether a test that measures a "Visual Evoked Potential" can be used in a new way for individuals that have hearing loss. This test measures the participant's brain's response (so called "brain waves") to specific visual images. This study will help the investigators determine whether this test could be used to improve treatments for patients with hearing loss. The "Visual Evoked Potential" measurement test is already used in the investigator's Neurology clinic at Dartmouth Hitchcock Medical Center for various conditions to measure "early" brain responses that occur in the first 1-2 seconds after a new cue. Our research aims to explore your brain's response just after that early 1-2 second period by looking at a specific response called the "P300". The P300 wave is a brain response to new or different images or sounds. A visual evoked P300 has not been studied in individuals with hearing loss. The investigators will compare the results of this test to standard auditory tests, tests of cognitive function, and cochlear implant patient outcomes to explore how these factors can predict successful use of a hearing aid or cochlear implant.
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2021-10-25; most recent amendment 2025-10-27.
Status change: Not Yet Recruiting → Recruiting 2023-07-24
Status change: Recruiting → Not Yet Recruiting 2023-03-13
Status change: Not Yet Recruiting → Recruiting 2022-02-08
Trial Details
NCT Number NCT05107466
Lead Sponsor Dartmouth-Hitchcock Medical Center
Collaborators: Dartmouth College
Conditions Sensorineural Hearing Loss, Hearing Loss
Enrollment 100 participants
Start Date 2023-07-28
Primary Completion 2026-08-01 (estimated)
Study Completion 2026-10-01 (estimated)
Updated on ClinicalTrials.gov 2025-10-29